Evan E. Opas

2.8k citations

34 papers · 2.0k indexed · 1 hit paper · h-index 18

Impact in

Orthopedics and Sports Medicine top 2%
- Bone health and osteoporosis research
- Bone and Joint Diseases
Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology

Papers in ⓘ

Molecular Biology 17
- Bone Metabolism and Diseases 5
- Receptor Mechanisms and Signaling 3
- Chemical Synthesis and Analysis 3
Oncology 12
- Chemokine receptors and signaling 6
- Bone health and treatments 5

Co-authors: Ronald E. Diehl (1 shared paper)Richard A. F. Dixon (1 shared paper)Jilly F. Evans (1 shared paper)Philip J. Vickers (1 shared paper)Elaine Rands (1 shared paper)Douglas K. Miller (1 shared paper)John W. Gillard (1 shared paper)Maurice B. Feinstein (2 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Biochemical Pharmacology (4 papers)Maturitas (3 papers)Bone (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Evan E. Opas

34 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis 1990 · 622 citations

Peers

Countries citing papers authored by Evan E. Opas

Since Specialization

Citations

This map shows the geographic impact of Evan E. Opas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan E. Opas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan E. Opas more than expected).

Fields of papers citing papers by Evan E. Opas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan E. Opas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan E. Opas. The network helps show where Evan E. Opas may publish in the future.

Co-authors

The 25 scholars most cited alongside Evan E. Opas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Evan E. Opas Line = papers co-authored together Evan E. Opas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis Nature ·Richard A. F. Dixon, Ronald E. Diehl, Evan E. Opas, Elaine Rands, Philip J. Vickers, Jilly F. Evans, John W. Gillard, Douglas K. Miller Hit paper breakdown →	1990	622
2	The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. Journal of Clinical Investigation ·R. Balena, Brian C. Toolan, M. Shea, A. Markatos, Elizabeth Myers, S C Lee, Evan E. Opas, J.G. Seedor, Hilton J. Klein, D. Frankenfield	1993	316
3	Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. Proceedings of the National Academy of Sciences ·A. Schmidt, Su Jane Rutledge, Naoto Endo, Evan E. Opas, Haruo Tanaka, Gregg Wesolowski, Chih‐Tai Leu, Zheng Huang, C Ramachandaran, Sevgi B. Rodan, Gideon A. Rodan	1996	170
4	Differential effects of calmodulin antagonists on phospholipases A2 and C in thrombin-stimulated platelets. Journal of Biological Chemistry ·Ronald W. Walenga, Evan E. Opas, Maurice B. Feinstein	1981	129
5	Prostaglandin and Leukotriene Synthesis in Mouse Ears Inflamed by Arachidonic Acid Journal of Investigative Dermatology ·Evan E. Opas, Robert J. Bonney, John L. Humes	1985	100
6	Prostaglandin E2-bisphosphonate conjugates: potential agents for treatment of osteoporosis Bioorganic & Medicinal Chemistry ·Laurent Frédéric Gil, Yongxin Han, Evan E. Opas, Gideon A. Rodan, Réjean Ruel, J.G. Seedor, Peter C. Tyler, Robert N. Young	1999	77
7	Reversal of thrombin-induced myosin phosphorylation and the assembly of cytoskeletal structures in platelets by the adenylate cyclase stimulants prostaglandin D2 and forskolin. Journal of Biological Chemistry ·Maurice B. Feinstein, John J. Egan, Evan E. Opas	1983	64
8	Autosomal Dominant Hypoparathyroidism Caused by Germline Mutation inGNA11: Phenotypic and Molecular Characterization The Journal of Clinical Endocrinology & Metabolism ·Li Dong, Evan E. Opas, Florin Tuluc, Daniel L. Metzger, Cuiping Hou, Håkon Håkonarson, Michael A. Levine	2014	61
9	Regulation of macrophage eicosanoid production by hydroperoxy-and hydroxy-eicosatetraenoic acids Biochemical Journal ·John L. Humes, Evan E. Opas, M Galavage, D.D. Soderman, Robert J. Bonney	1986	53
10	Human protein tyrosine phosphatase-σ: Alternative splicing and inhibition by bisphosphonates Journal of Bone and Mineral Research ·Naoto Endo, Su Jane Rutledge, Evan E. Opas, Robert L. Vogel, Gideon A. Rodan, Azriel Schmidt	1996	49
11	Estrogenic control of thermoregulation in ERαKO and ERβKO mice Maturitas ·Evan E. Opas, Michael A. Gentile, Donald B. Kimmel, Gideon A. Rodan, Azriel Schmidt	2005	30
12	Alendronate inhibition of protein-tyrosine-phosphatase-meg1 Biochemical Pharmacology ·Evan E. Opas, Su Jane Rutledge, Ellis E. Golub, Andrew M. Stern, Zoran Zimoio, Gideon A. Rodan, Azriel Schmidt	1997	27
13	The Discovery and Biologic Properties of Cephalosporin‐Based Inhibitors of PMN Elastase Annals of the New York Academy of Sciences ·Philip R. Davies, Bonnie M. Ashe, Robert J. Bonney, Conrad P. Dorn, Paul E. Finke, D. Fletcher, William A. Hanlon, John L. Humes, Alan L. Maycock, Richard A. Mumford, Manuel A. Navia, Evan E. Opas, Stephen G Pacholok, S Shah, M.D. Zimmerman, James B. Doherty	1991	24
14	Rat tail skin temperature regulation by estrogen, phytoestrogens and tamoxifen Maturitas ·Evan E. Opas, Su Jane Rutledge, Robert L. Vogel, Gideon A. Rodan, Azriel Schmidt	2004	23
15	Pharmacological modulation of eicosanoid levels and hyperalgesia in yeast-induced inflammation Biochemical Pharmacology ·Evan E. Opas, Aimée Dallob, E Herold, Silvi Luell, John L. Humes	1987	23
16	Effects of cyclooxygenase and lipoxygenase inhibitors on inflammation associated with oxazolone-induced delayed hypersensitivity Biochemical Pharmacology ·Roger Meurer, Evan E. Opas, John L. Humes	1988	22
17	Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists Bioorganic & Medicinal Chemistry Letters ·Xuqing Zhang, Heather R. Hufnagel, Thomas Markotan, James C. Lanter, Chaozhong Cai, Cuifen Hou, Monica Singer, Evan E. Opas, Sandra McKenney, Carl Crysler, Dana L. Johnson, Zhihua Sui	2011	18
18	A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists Bioorganic & Medicinal Chemistry Letters ·Nalin L. Subasinghe, James C. Lanter, Thomas Markotan, Evan E. Opas, Sandra McKenney, Carl Crysler, Cuifen Hou, John O’Neill, Dana L. Johnson, Zhihua Sui	2012	17
19	Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells The Journal of Steroid Biochemistry and Molecular Biology ·Azriel Schmidt, Robert Meißner, Michael A. Gentile, Michael Chisamore, Evan E. Opas, Angela Scafonas, Tara E. Cusick, Carlo J. Gambone, Brenda L Pennypacker, Paul Hodor, James J. Perkins, Chang Bai, Damien Ferraro, David Bettoun, Hilary Wilkinson, Stephen E. Alves, Osvaldo Flores, William J. Ray	2014	17
20	Control of rat tail skin temperature regulation by estrogen receptor-beta selective ligand Maturitas ·Evan E. Opas, Angela Scafonas, Pascale V. Nantermet, Robert R. Wilkening, Elizabeth T. Birzin, Hilary Wilkinson, Lawrence F. Colwell, James M. Schaeffer, Dwight A. Towler, Gideon A. Rodan, Azriel Schmidt	2009	17

About Evan E. Opas

Evan E. Opas is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Endocrinology, Diabetes and Metabolism, having authored 34 papers that have together received 2.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (7 papers), Chemokine receptors and signaling (6 papers), Inflammatory mediators and NSAID effects (5 papers), Bone health and treatments (5 papers), Bone Metabolism and Diseases (5 papers), Receptor Mechanisms and Signaling (3 papers), Chemical Synthesis and Analysis (3 papers) and Menopause: Health Impacts and Treatments (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (379 citations), Biochemistry (180 citations), Oncology (594 citations), Pharmacology (269 citations) and Physiology (359 citations). Evan E. Opas has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Ronald E. Diehl, Richard A. F. Dixon, Jilly F. Evans, Philip J. Vickers, Elaine Rands, Douglas K. Miller, John W. Gillard, Maurice B. Feinstein, John L. Humes and Gideon A. Rodan. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Biochemical Pharmacology, Maturitas, Bone and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact